Clinical Trial Update: Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is testing an adoptive T cell therapy combined with a DC/AML fusion vaccine plus decitabine and venetoclax in acute myeloid leukemia, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Adoptive T Cell Therapy
• DC/AML fusion vaccine
• Dacogen (decitabine)
• Venclexta (venetoclax)

Snippet

Sponsor: David Avigan | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse | Phase 1 | Status: NOT_YET_RECRUITING